1-20 of 53
Keywords: Acute lymphoblastic leukemia
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Acta Haematol (2024) 147 (4): 391–401.
Published Online: 14 November 2023
...Fausto A. Rios-Olais; Fernando Gil-Lopez; Analy Mora-Cañas; Roberta Demichelis-Gómez Introduction: Tumor lysis syndrome (TLS) occurs frequently during induction therapy for acute lymphoblastic leukemia (ALL). Patients are categorized into intermediate- or high-risk based on the lactate...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Acta Haematol (2016) 135 (4): 208–210.
Published Online: 04 February 2016
...Ruham Alshiekh-Nasany; Dan Douer Introduction: Similar to pediatric regimens, multiple doses of L -asparaginase (PEG-Asp) are being increasingly used in adults with newly diagnosed acute lymphoblastic leukemia (ALL) with promising results. One of the most common side effects of the drug in adults...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2014) 132 (3-4): 264–273.
Published Online: 10 September 2014
...Patrick W. Burke; Dan Douer The cure rate of acute lymphoblastic leukemia (ALL) in children is 80%, compared to less than half in adults. A major proportion of this cure rate drop occurs in adolescents and young adults (AYAs). The age range defining this population varies between studies...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2014) 133 (1): 91–97.
Published Online: 23 August 2014
... is a conventional agent for relapsed or refractory acute lymphoblastic leukemia (ALL). However, an effective combination with other drugs and a feasible dosage has not been identified. A retrospective study of 46 patients with relapsed or refractory ALL was conducted to determine the efficacy of mitoxantrone...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2013) 130 (3): 188–191.
Published Online: 11 June 2013
... for immunophenotyping of this malignancy. Treatment regimens for precursor B-cell ALL are suitable for such cases. Precursor B cell Acute lymphoblastic leukemia Immunophenotype Surface immunoglobulin light chain B-cell acute lymphocytic leukemia (ALL) can be classified into precursor B- and mature B-cell...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2013) 129 (4): 207–214.
Published Online: 15 May 2013
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2013 Acute lymphoblastic leukemia Molecular mechanism Bortezomib Acute lymphocytic leukemia (ALL) is a malignant disorder that originates from one single hematopoietic...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2013) 129 (4): 232–237.
Published Online: 11 January 2013
... could suggest increased expression of HERV-K in leukemic cells. To elucidate the role of endogenous retroviruses in leukemogenesis, studies were undertaken to assess env gene expression of HERV-K and HERV-W in childhood acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Results...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2013) 129 (2): 121–125.
Published Online: 28 November 2012
... risk for developing acute lymphoblastic leukemia and acute myeloid leukemia (AML). Case Report: A 33-year-old male XP patient was diagnosed with acute megakaryoblastic leukemia with a complex karyotype. He received standard induction chemotherapy with cytarabine and daunorubicin. After the first cycle...